Compare ALTO & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALTO | LAB |
|---|---|---|
| Founded | 2003 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Biotechnology: Laboratory Analytical Instruments |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 420.7M | 347.5M |
| IPO Year | 2005 | 2008 |
| Metric | ALTO | LAB |
|---|---|---|
| Price | $5.18 | $0.86 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $1.35 |
| AVG Volume (30 Days) | 2.6M | ★ 5.0M |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 119.51 | 61.54 |
| EPS | 0.05 | ★ 0.33 |
| Revenue | ★ $917,927,000.00 | $101,937,000.00 |
| Revenue This Year | $6.66 | N/A |
| Revenue Next Year | $0.43 | $2.63 |
| P/E Ratio | $103.90 | ★ $2.56 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.92 | $0.70 |
| 52 Week High | $6.11 | $1.72 |
| Indicator | ALTO | LAB |
|---|---|---|
| Relative Strength Index (RSI) | 44.56 | 47.94 |
| Support Level | $4.27 | $0.79 |
| Resistance Level | $6.02 | $1.02 |
| Average True Range (ATR) | 0.39 | 0.07 |
| MACD | -0.05 | 0.01 |
| Stochastic Oscillator | 19.83 | 60.45 |
Alto Ingredients Inc is a producer and distributor of specialty alcohols, renewable fuels and essential ingredients in the United States. The company serves five markets: Health, Home and Beauty, Food and Beverage, Essential Ingredients, and Renewable Fuels. Its customers include food and beverage companies and consumer products manufacturers and distributors. The company operates under three segments: Marketing and distribution, Pekin Campus production, and Western production.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. The company operates in one segment. Its technology includes: Genomics; Single-cell proteomics; Spatial proteomics. Its platforms include: Biomark X9 System, CyTOF XT system, and Hyperion XTi Imaging System. The company offers a diverse range of instrumentation, consumables, and services that generate high-quality data across early discovery, translational and clinical research. Geographically, it operates in Americas; EMEA and Asia-Pacific.